You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

targeted agents

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Melanoma, Glioma, Thyroid Cancer Trial (PF-07799544, PF-07284890, PF-07799933)

Not yet recruiting
  • Melanoma
  • +6 more
  • (no location specified)
Sep 9, 2022

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Soft Tissue Sarcoma Adult Trial (Surufatinib)

Not yet recruiting
  • Soft Tissue Sarcoma Adult
  • (no location specified)
Oct 29, 2023

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +9 more
Jan 3, 2023

Prostate Cancer, Prostatic Adenocarcinoma Trial in New York (degarelix injection, androgen deprivation therapy)

Active, not recruiting
  • Prostate Cancer
  • Prostatic Adenocarcinoma
  • degarelix injection
  • androgen deprivation therapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 28, 2022

Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +7 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Metastatic Oncogen-driven Cancer Trial in Villejuif (Biopsy)

Recruiting
  • Metastatic Oncogen-driven Cancer
  • Biopsy
  • Villejuif, Val De Marne, France
    Gustave Roussy Cancer Campus Grand Paris
Feb 23, 2021

Advanced Renal Cell Carcinoma Trial in Rochester (Carevive software)

Recruiting
  • Advanced Renal Cell Carcinoma
  • Carevive software
  • Rochester, New York
    University of Rochester - Wilmot Cancer Institute
Jan 4, 2022

NSCLC Trial in United States (Pembrolizumab, Carboplatin, Pemetrexed)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Chicago, Illinois
  • +6 more
Sep 9, 2021

Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,

Recruiting
  • Disease Free Survival
  • +2 more
  • use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
  • Milan, Italy
    IRCCS San Raffaele
Mar 7, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory

Active, not recruiting
Has Results
  • Castration Levels of Testosterone
  • +9 more
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Breast Cancer, Prostate Cancer, Metastasis Trial in Ottawa (Pamidronate, Denosumab, Zoledronate)

Completed
  • Breast Cancer
  • +2 more
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Research Institute
Dec 1, 2020

Melanoma Trial (ONCOS-102, Balstilimab)

Not yet recruiting
  • Melanoma
  • ONCOS-102
  • Balstilimab
  • (no location specified)
Oct 24, 2022

Solid Tumors, Advanced Cancer Trial in Houston (Anastrozole, Bevacizumab, Everolimus)

Completed
  • Solid Tumors
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 20, 2021

Advanced Solid Tumor Trial in Worldwide (Arm 1 - atezolizumab)

Recruiting
  • Advanced Solid Tumor
  • Arm 1 - atezolizumab
  • Villejuif, France
  • +5 more
Oct 4, 2021

Schizophrenia; Psychosis, Metabolic Syndrome, Flupentixol Trial in Taichung (Flupentixol, Multi-acting receptor-targeted

Completed
  • Schizophrenia; Psychosis
  • +7 more
  • Flupentixol
  • Multi-acting receptor-targeted antipsychotics (MARTAs)
  • Taichung, Taiwan
    Taichung Veterans General Hospital
May 20, 2021

Biliary Tract Tumors, Gastric Cancer, Esophageal Squamous Cell Carcinoma Trial in Beijing (FGFR Inhibitor, IDH1 Inhibitor, HER2

Unknown status
  • Biliary Tract Neoplasms
  • +8 more
  • FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
  • Other Therapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Oct 8, 2020

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6

Not yet recruiting
  • Grade 3b Follicular Lymphoma
  • +5 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 6, 2023

Tumor Metastasis, Colorectal Tumors, Breast Cancer Trial in United States (Prexasertib, Cisplatin, Cetuximab)

Completed
  • Neoplasm Metastasis
  • +2 more
  • Sarasota, Florida
  • +4 more
Mar 30, 2020

Prostate Cancer Metastatic Trial in France (Darolutamide 300 mg, Placebo, Androgen deprivation therapy)

Recruiting
  • Prostate Cancer Metastatic
  • Darolutamide 300 mg
  • +2 more
  • Avignon, France
  • +44 more
Sep 28, 2022

Respiratory Distress Syndrome, Adult Trial in United States (Hypothermia, Neuromuscular Blocking Agents, Standard of care)

Recruiting
  • Respiratory Distress Syndrome, Adult
  • Hypothermia
  • +2 more
  • Atlanta, Georgia
  • +14 more
Oct 5, 2022

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Advanced Solid Tumours, Actinium-225, Antineoplastic Agents Trial in Australia, Canada, United States ([111In]-FPI-1547

Recruiting
  • Advanced Solid Tumours
  • +4 more
  • [111In]-FPI-1547 Injection
  • +3 more
  • Duarte, California
  • +12 more
Mar 2, 2022

Respiratory Distress Syndrome, Adult, Sars-CoV2 Trial in Baltimore (Hypothermia, Neuromuscular Blocking Agents, Standard of

Withdrawn
  • Respiratory Distress Syndrome, Adult
  • Sars-CoV2
  • Hypothermia
  • +2 more
  • Baltimore, Maryland
    University of Maryland Medical Center
Apr 27, 2021